Weedstocks Newswire Feed
Bruce Linton to Continue as Chairman of the Board
TORONTO, May 22, 2019 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSXV: RIV) today announced the promotion of former OMERS venture capitalist and Canopy Rivers President, Mr. Narbé Alexandrian, to Chief Executive Officer of the Company, effective immediately. Bruce Linton has transitioned from his role as acting CEO and will continue to provide oversight, deal flow, strategic insight, and opportunities for collaboration and further strategic alignment with Canopy Growth in conjunction with his ongoing role as Chairman of the Canopy Rivers Board of Directors.
"I am extremely proud of what Canopy Rivers has accomplished since the Company's inception and Canopy Growth's initial seed investment. We first invested in Canopy Rivers on the thesis that our equity and strategic support relationship would provide Canopy Growth with exposure to a diversified portfolio of cannabis investments in specialized and innovative businesses throughout the global cannabis industry. Today, Canopy Rivers has a diversified and integrated portfolio of 17 domestic and international investments that includes exposure to the majority of the industry value chain. These businesses collaborate and draw insight from each other and Canopy Growth such that the entire Canopy ecosystem of companies can navigate the industry more efficiently and cost effectively," said Bruce Linton, Co-CEO of Canopy Growth and Chairman of Canopy Rivers. "We have aspired to build the Canopy Rivers team using the same approach we use to build our portfolio - by identifying specialists with diversified but complementary skillsets and having them leverage their individual areas of expertise to create value for our portfolio partners and shareholders," continued Linton. "After working directly with Narbe and seeing him excel in several internal roles since we recruited him from OMERS, the Board of Directors and I believe that he is the ideal candidate to lead the Company going forward to continue to build value for all Canopy Rivers shareholders."
"I would like to thank Bruce, the Board of Directors, and the entire team at Canopy Rivers for the privilege and opportunity to build upon the impressive portfolio and platform that has been developed to date," said Narbé Alexandrian, President and CEO of Canopy Rivers. "With the global cannabis economy continuing to evolve and expand at a lightspeed pace, I am both humbled and thrilled to have been chosen to lead the Company at this incredibly important juncture," continued Alexandrian. "Canopy Rivers is committed to being the world's preeminent cannabis-focused investment and strategic support platform by providing diverse, thesis-driven exposure to the cutting edge of the cannabis value chain, working collaboratively and transparently with our investors and portfolio companies, and generating superior long-term investment returns for our shareholders. I have every confidence we can realize each of these goals, and we welcome the challenge."
Prior to joining Canopy Rivers, Narbe was a venture capitalist at OMERS Ventures, where he sourced and lead private debt and equity investments, raised more than $500 million of new investment capital, and acted as a board observer for several of the firm's portfolio companies. Prior to OMERS Ventures, Narbe was at TELUS' Internet of Things Group, where he helped develop and launch operational and go-to-market strategies in collaboration with the TELUS executive leadership team. Narbe has also held roles at Firmex Inc. in corporate development and Deloitte LLP in both Financial Advisory and Consulting.
NAPANEE, ON, May 22, 2019 /CNW/ - VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has signed a distribution agreement with Burleigh Heads Cannabis Pty Ltd. ("Burleigh Heads"), one of Australia's leading medicinal cannabis distributors. The agreement is expected to increase the ability of Australian patients to access VIVO's high-quality medicinal cannabis flower, oil and other products via approved channels.
The required regulatory import permits necessary to enable the first shipment of product under the agreement have been granted by the Australia Office of Drug Control, and Burleigh Heads expects to import the first shipment of VIVO products in June, subject to receipt of a Canadian export permit.
Barry Fishman, CEO of VIVO, stated, "We are very excited to announce the signing of this distribution agreement, which will give us increased exposure in the Australian market and enhance consumer awareness of our brand and products. Burleigh Heads is a strong advocate for improving patient access to safe cannabis medicines and, together with its affiliate, CDA Clinics Australia, is a leader in providing Australian patients with channels through which to acquire high-quality cannabis products."
Guy Headley, Director of Operations of Burleigh Heads, commented, "We are impressed with VIVO's commitment to product quality and patient access. We look forward to providing Australian patients and doctors with another quality medicinal cannabis treatment option. We also look forward to continuing this relationship with VIVO as their product portfolio expands."
Visit our website to sign up for VIVO Cannabis updates: https://www.vivocannabis.com/contact/
Meet Your New Neighbour: It's Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Meadow Lake, SK
MEADOW LAKE, SK, May 22, 2019 /CNW/ - We're growing (in more ways than one)!
Tweed, Canada's top cannabis producer, is excited to announce the May 23rd grand opening of their Meadow Lake retail location with a celebration of fun, education and most importantly, community love!
Legal cannabis is new to many consumers but we've been cutting our teeth as a medical producer for years so we can help suggest strains and educate on the different ways to consume cannabis.
We want to invite you, our local media friends, to learn and experience a 'Tweedtender' one-on-one introduction to the Tweed brand, our products, our presence in your city and our commitment to local community involvement.
The team at Tweed's Centre Street store looks forward to meeting the neighbours in Meadow Lake and creating a hub for adult recreational cannabis education and culture.
VANCOUVER, British Columbia, May 22, 2019 /CNW/ -- Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") (CSE: SNN) (OTCQB: SNNVF), a North American provider of cannabis products and services, announces Leith Pedersen, President, Chief Strategy Officer and Co-Founder of the Company has resigned as an officer and a director, effective immediately, for personal reasons. His responsibilities will be absorbed by the senior leadership team of the Company.
Dr. Anthony Holler, Chairman and CEO, commented, "On behalf of the entire Sunniva organization, I want to express my gratitude to Leith for his contributions to Sunniva over the past several years. Leith and I founded Sunniva together in 2014 and thanks in large part to his vision, energy and passion, Sunniva has progressed to be an emerging player in the California cannabis industry. We wish Leith all the best in his future endeavors."
For more information please visit: www.sunniva.com
To be added to the Sunniva email distribution list please register at www.sunniva.com/email-alerts.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
TORONTO, May 22, 2019 /CNW/ - Newstrike Brands Ltd. (TSX-V:HIP) ("Newstrike" or the "Company") today announced that it has obtained a final court order from the Ontario Superior Court of Justice approving the previously announced plan of arrangement under the Business Corporations Act (Ontario), in which HEXO Corp. ("HEXO") (TSX: HEXO; NYSE-A: HEXO) will acquire all of Newstrike's issued and outstanding common shares by way of a plan of arrangement under the Business Corporations Act (Ontario) (the "Arrangement").
Receipt of the final order follows the annual and special meeting of shareholders of Newstrike held on May 17, 2019, where shareholders approved the Arrangement by a special resolution.
Pursuant to the Arrangement, holders of common shares of Newstrike will receive 0.06332 shares of HEXO for each common share of Newstrike held. Closing of the Arrangement remains subject to the satisfaction (or waiver) of other customary closing conditions, including final approval by the TSX Venture Exchange. Subject to satisfaction of these closing conditions, it is anticipated that the Arrangement will be completed on or around May 24, 2019.
About Newstrike and Up Cannabis
Newstrike is the parent company of Up Cannabis Inc., a licensed producer of cannabis that is licensed to both cultivate and sell cannabis in all acceptable forms. Newstrike, through Up Cannabis and together with select strategic partners, including Canada's iconic musicians The Tragically Hip, is developing a diverse network of high quality cannabis brands. For more infcormation, visit http://www.up.ca or http://www.newstrike.ca
CV Sciences, Inc. Applauds California Assembly Support of Hemp-derived CBD products through Unanimous Passing of AB 228
Ethicann Pharmaceuticals Forms Partnership with Ilera Therapeutics for the Development and Manufacture of Botanical THC to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)
TORONTO, May 22, 2019 /CNW/ - Ethicann Pharmaceuticals Inc., a Toronto-based ethical pharmaceutical company, today announced a development and commercial supply partnership with Ilera Therapeutics LLC (Newtown Square, Pennsylvania). Ethicann was founded in 2018 as a pharma enterprise with a global focus by executives and investors with extensive experience in the Canadian and U.S. pharmaceutical and Canadian cannabis industries. Ethicann's strict focus is the commercialization of cannabis-based ethical drugs that will be submitted for marketing approvals to Health Canada, the U.S. Food and Drug Administration and other global pharma regulatory authorities. Ethicann completed its initial financing earlier this year.
Ilera Therapeutics is part of the Ilera group of companies that are leading licensed growers/extractors of cannabis products in Pennsylvania and Louisiana, selling botanical cannabinoid oils and related products to medical marijuana dispensaries in each state. Moreover, the members of Ilera Therapeutics' management team and Board have highly respected global pharma backgrounds, headed by Chairman Osagie Imasogie--who held senior executive positions at GlaxoSmithKline and Dupont Merck. In their partnership, the two companies share a keen interest in the development and commercialization of cannabis-based pharmaceuticals that target important disease areas and that will be subject to the rigors of global drug regulatory review.
Ilera Therapeutics will develop and manufacture a highly purified botanical THC-based product that can be used by Ethicann to conduct a limited clinical study to support a market approval application that Ethicann will file initially in the United States for its CAN-001 product. Ethicann will then seek approvals in other global markets, using the same clinical data.
CAN-001 is a treatment for chemotherapy-induced nausea and vomiting (CINV), which occurs in approximately 80% of the new 23.6 million cases of cancer annually worldwide. The global market for treating CINV with THC is estimated at USD $2.66 billion.
FORWARD LOOKING STATEMENT: